# Donepezil in the Prevention of Post-Operative Cognitive Decline

> **NCT00182845** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (—)

## Conditions studied

- Postoperative Complications
- Delirium

## Interventions

- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00182845
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182845, "Donepezil in the Prevention of Post-Operative Cognitive Decline". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00182845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*